Product Name | Amifostine Trihydrate | WR2721 trihydrate |
---|---|
CAS | 112901-68-5 |
Formula | C5H21N2O6PS |
MW | 268.27 |
Appearance | White crystal or crystalline powder |
Storage condition | 4°C, protect from light, stored under nitrogen |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
50 mg | In-stock | ¥350.00 | Visible after login | |
100 mg | In-stock | ¥500.00 | Visible after login | |
200 mg | In-stock | ¥800.00 | Visible after login |
Product Name | Amifostine Trihydrate | WR2721 trihydrate |
---|---|
CAS | 112901-68-5 |
Formula | C5H21N2O6PS |
MW | 268.27 |
Appearance | White crystal or crystalline powder |
Storage condition | 4°C, protect from light, stored under nitrogen |
Amifostine trihydrate(WR2721 trihydrate) is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.
PMID: 28392886 PMCID: PMC5368387 DOI: 10.1155/2017/4130824
Amifostine: the first selective-target and broad-spectrum radioprotector.
PMID: 17602063 DOI: 10.1634/theoncologist.12-6-738
Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha.
PMID: 14574457 DOI: 10.1007/s00280-003-0691-z